HBA NY/NJ Region presents

The Digital Health Disruption: How it Enhances Patient Care

Date and time


Event contact

Danielle Maddiboina





Event sponsors


Digital health disruption is evolving the role of the patient in the health care industry. A panel of innovative healthcare and industry leaders will share their perspectives on how digital healthcare is revolutionizing patient identification, engagement, access, and outcomes. Explore how digital tools for patient participation, real world data, and artificial intelligence are impacting patient contribution to drug development, from basic and clinical research through commercialization.

This event is facilitated by HBA NY/NY region’s Women in Science (WIS) affinity group. Affinity groups are self-forming communities of HBA members who connect through a common interest, focus or need associated with their career and professional aspirations. Participation in HBA’s career-specific affinity groups grants members access to professional development through networking, education and career support. For more information about WIS, please inquire at the event registration.

5:30 - 6:30 PM      Registration and networking
6:30 - 6:45 PM      Welcome and introductions
6:45 - 7:00 PM      Keynote presentation
7:00 - 8:00 PM      Panel and Q & A
8:00 - 8:30 PM      Closing remarks and networking

Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: 27 September 2018
Onsite (walk-in) registration: Is NOT allowed

This event is refundable. All refund requests must be submitted in writing to events@hbanet.org by 20 September 2018. No refunds are available after this date.


Featured speakers

John O'Donnell

Vice president, worldwide health economics and outcomes research

Bristol-Myers Squibb Company

Marisa Co

Head of research and development, business insights and analytics

Bristol-Myers Squibb Company

Rebecca Miksad

Senior medical director, research oncology

Flatiron Health

Joseph Szustakowski

Head of transitional medicine, bioinformatics

Bristol-Myers Squibb Company

David Fuehrer


GRYT Health

Joe Lengfellner

Director, clinical research informatics and technology

Memorial Sloan-Kettering Cancer Center


Learning objectives

1. Define digital health and increase awareness of how technology, big data, and artificial intelligence are disrupting the health industry.
2. Expand knowledge of the emerging role of digital tools in improving patient engagement, access, and health outcomes.
3. Gain insight on how patient participation via digital tools can advance emerging therapies through research and development, clinical trials, and commercialization.


Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.


 Registration NamePrice LevelRegular

RegistrationName 1 - Regular registration

 1 - Regular registrationMember$30.00
 1 - Regular registrationNon-Member$45.00

RegistrationName 2 - Bristol Myers Squibb employees

 2 - Bristol Myers Squibb employeesNon-Member$30.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.